Last reviewed · How we verify

NCT07121894

Ketogenic Intervention for Bipolar Depression

Recruiting now NA Last updated 26 January 2026
What this trial tests

NA trial testing Ketogenic Diet in Bipolar Depression in 30 participants. Currently enrolling.

Timeline
12 August 2025
Primary endpoint
31 December 2028
1 May 2029

Quick facts

Lead sponsorMayo Clinic
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment30
Start date12 August 2025
Primary completion31 December 2028
Estimated completion1 May 2029
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Mayo Clinic

Who can join

Adults 18 to 50, any sex, with Bipolar Depression. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to assess the clinical correlates of therapeutic precision ketosis in bipolar depression and to evaluate the cardiometabolic correlates associated with therapeutic precision ketosis in bipolar depression.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Ketogenic Diet

Trials testing the same drug.

Other recruiting trials for Bipolar Depression

Currently open trials in the same condition.

Other Mayo Clinic trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07121894.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing